Association between endothelin receptor B nonsynonymous variants and melanoma risk

Journal of the National Cancer Institute

Volumn 97, Issue 17, 2005, Pages 1297-1301

  Soufir, Nadem ^a   Meziani, Roubila ^a   Lacapère, Jean Jacques ^a   Bertrand, Guylene ^a   Fumeron, Frederic ^b   Bourillon, Agnes ^a   Gérard, Bénédicte ^a   Descamps, Vincent ^a   Crickx, Béatrice ^a   Ollivaud, Laurence ^c   Archimbaud, Alain ^c   Lebbe, Céleste ^c   Basset Seguin, Nicole ^c   Saiag, Philippe ^d   Grandchamp, Bernard ^a  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN B RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; ETHNOLOGY; EYE COLOR; FEMALE; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC DISORDER; GENETIC VARIABILITY; GERM LINE; HAIR COLOR; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN TISSUE; LENTIGO; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEVUS; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ANALYSIS; SKIN COLOR; STATISTICAL SIGNIFICANCE; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PROSPECTIVE STUDY; RISK; SKIN TUMOR; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GERM-LINE MUTATION; HIRSCHSPRUNG DISEASE; HUMANS; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; RECEPTOR, ENDOTHELIN B; SKIN NEOPLASMS;

EID: 24744455058     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji253     Document Type: Article

References (58)

1. Dreno B, Wallon-Dumont G. Epidemiology of melanoma. Presse Med 2003;32:30-2. [In French.]
2. Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995;62: 367-76.
3. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, et al. Analysis of the p 16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994;8:23-6.
4. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, et al. Germline p 16 mutations in familial melanoma. Nat Genet 1994;8:15-21.
5. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996;12:97-9.
6. Holland EA, Schmid H, Kefford RF, Mann GJ. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 1999;25:339-48.
7. Winsey SL, Haldar NA, Marsh HP, Bunce M, Marshall SE, Harris AL, et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000;60:5612-6.
8. Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, et al. Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomarkers Prev 2001;10:509-13.
9. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000;66:176-86.
10. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001;117:294-300.
11. Hayward NK. Genetics of melanoma predisposition. Oncogene 2003;22:3053-62.
12. Levin ER. Endothelins. N Engl J Med 1995; 333:356-63.
13. Shin MK, Levorse JM, Ingram RS, Tilghman SM. The temporal requirement for endothelin receptor-B signalling during neural crest development. Nature 1999;402: 496-501.
14. Reid K, Turnley AM, Maxwell GD, Kurihara Y, Kurihara H, Bartlett PF, et al. Multiple roles for endothelin in melanocyte development: Regulation of progenitor number and stimulation of differentiation. Development 1996;122:3911-9.
15. Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 1994;79:1267-76.
16. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 1994;79:1257-66.
17. Matsushima Y, Shinkai Y, Kobayashi Y, Sakamoto M, Kunieda T, Tachibana M. A mouse model of Waardenburg syndrome type 4 with a new spontaneous mutation of the endothelin-B receptor gene. Mamm Genome 2002;13:30-5.
18. Attie T, Till M, Pelet A, Amiel J, Edery P, Boutrand L, et al. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet 1995;4:2407-9.
19. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995;105:32-7.
20. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992;267:24675-80.
21. Ahn GY, Butt KI, Jindo T, Yaguchi H, Tsuboi R, Ogawa H. The expression of endothelin-1 and its binding sites in mouse skin increased after ultraviolet B irradiation or local injection of tumor necrosis factor alpha. J Dermatol 1998;25:78-84.
22. Tada A, Suzuki I, Im S, Davis MB, Cornelius J, Babcock G, et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ 1998;9:575-84.
23. Matichard E, Verpillat P, Meziani R, Gerard B, Descamps V, Legroux E, et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 2004;41:e13.
24. Roos M, Soskic V, Poznanovic S, Godovac-Zimmermann J. Post-translational modifications of endothelin receptor B from bovine lungs analyzed by mass spectrometry. J Biol Chem 1998;273:924-31.
25. Fuchs S, Amiel J, Claudel S, Lyonnet S, Corvol P, Pinet F. Functional characterization of three mutations of the endothelin B receptor gene in patients with Hirschsprung's disease: Evidence for selective loss of Gi coupling. Mol Med 2001;7:115-24.
26. Imamura F, Arimoto I, Fujiyoshi Y, Doi T. W276 mutation in the endothelin receptor subtype B impairs Gq coupling but not Gi or Go coupling. Biochemistry 2000;39: 686-92.
27. Abe Y, Sakurai T, Yamada T, Nakamura T, Yanagisawa M, Goto K. Functional analysis of five endothelin-B receptor mutations found in human Hirschsprung disease patients. Biochem Biophys Res Commun 2000;275: 524-31.
28. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: Server and survey Nucleic Acids Res 2002;30:3894-900.
29. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999;22: 231-8.
30. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 1999;22:239-47.
31. Kreitman M, Comeron JM. Coding sequence evolution. Curr Opin Genet Dev 1999;9: 637-41.
32. Eberle J, Weitmann S, Thieck O, Pech H, Paul M, Orfanos CE. Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes. J Invest Dermatol 1999;112:925-32.
33. Smith SL, Damato BE, Scholes AG, Nunn J, Field JK, Heighway J. Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. Br J Cancer 2002;87:1308-13.
34. Kikuchi K, Nakagawa H, Kadono T, Etoh T, Byers HR, Mihm MC, et al. Decreased ET(B) receptor expression in human metastatic melanoma cells. Biochem Biophys Res Commun 1996;219:734-9.
35. Hofstra RM, Osinga J, Tan-Sindlunata G, Wu Y, Kamsteeg EJ, Stulp RP, et al. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet 1996;12:445-7.
36. Amiel J, Attie T, Jan D, Pelet A, Edery P, Bidaud C, et al. Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum Mol Genet 1996;5:355-7.
37. Auricchio A, Casari G, Staiano A, Ballabio A. Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population. Hum Mol Genet 1996;5:351-4.
38. Kusafuka T, Wang Y, Puri P. Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung's disease. Hum Mol Genet 1996;5:347-9.
39. Kusafuka T, Wang Y, Puri P. Mutation analysis of the RET, the endothelin-B receptor, and the endothelin-3 genes in sporadic cases of Hirschsprung's disease. J Pediatr Surg 1997;32:501-4.
40. Hofstra RM, Osinga J, Buys CH. Mutations in Hirschsprung disease: When does a mutation contribute to the phenotype. Eur J Hum Genet 1997;5:180-5.
41. Inoue M, Hosoda K, Imura K, Kamata S, Fukuzawa M, Nakao K, et al. Mutational analysis of the endothelin-B receptor gene in Japanese Hirschsprung's disease. J Pediatr Surg 1998;33:1206-8.
42. Tanaka H, Moroi K, Iwai J, Takahashi H, Ohnuma N, Hori S, et al. Novel mutations of the endothelin B receptor gene in patients with Hirschsprung's disease and their characterization. J Biol Chem 1998;273:11378-83.
43. Syrris P, Carter ND, Patton MA. Novel nonsense mutation of the endothelin-B receptor gene in a family with Waardenburg-Hirschsprung disease. Am J Med Genet 1999;87:69-71.
44. Sakai T, Nirasawa Y, Itoh Y, Wakizaka A. Japanese patients with sporadic Hirschsprung: Mutation analysis of the receptor tyrosine kinase proto-oncogene, endothelin-B receptor, endothelin-3, glial cell line-derived neurotrophic factor and neurturin genes: A comparison with similar studies. Eur J Pediatr 2000;159:160-7.
45. Garcia-Barcelo M, Sham MH, Lee WS, Lui VC, Chen BL, Wong KK, et al. Highly recurrent RET mutations and novel mutations in genes of the receptor tyrosine kinase and endothelin receptor B pathways in Chinese patients with sporadic Hirschsprung disease. Clin Chem 2004;50:93-100.
46. Auricchio A, Griseri P, Carpentieri ML, Betsos N, Staiano A, Tozzi A, et al. Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. Am J Hum Genet 1999;64:1216-21.
47. Kemp BE, Pearson RB. Protein kinase recognition sequence motifs. Trends Biochem Sci 1990;15:342-6.
48. Svensson PJ, Anvret M, Molander ML, Nordenskjold A. Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B). Hum Genet 1998;103:145-8.
49. Amiel J, Salomon R, Attie-Bitach T, Touraine R, Steffann J, Pelet A, et al. Molecular genetics of Hirschsprung disease: A model of multigenic neurocristopathy. J Soc Biol 2000;194:125-8. [In French.]
50. Pusch CM, Sasiadek MM, Blin N. Hirschsprung, RET-SOX and beyond: The challenge of examining non-mendelian traits (Review). Int J Mol Med 2002;10:367-70.
51. McCallion AS, Stames E, Conlon RA, Chakravarti A. Phenotype variation in two-locus mouse models of Hirschsprung disease: Tissue-specific interaction between Ret and Ednrb. Proc Natl Acad Sci U S A 2003;100:1826-31.
52. Carrasquillo MM, McCallion AS, Puffenberger EG, Kashuk CS, Nouri N, Chakravarti A. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 2002;32: 237-44.
53. Newton Bishop JA, Bataille V, Pinney E, Bishop DT. Family studies in melanoma: Identification of the atypical mole syndrome (AMS) phenotype. Melanoma Res 1994;4:199-206.
54. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869-71.
55. Ringholm A, Klovins J, Rudzish R, Phillips S, Rees JL, Schioth HB. Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol 2004;123:917-23.
56. Sturm RA. Skin colour and skin cancer-MC1R, the genetic link. Melanoma Res 2002;12:405-16.
57. Mas JS, Sanchez CO, Ghanem G, Haycock J, Teruel JA, Garcia-Borron JC, et al. Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur J Biochem 2002;269: 6133-41.
58. Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996;5:1663-6.